Periorbital edema secondary to imatinib mesylate
Collin M McClelland, George J Harocopos, Philip L CusterSchool of Medicine, Washington University, St. Louis, MO, USAAbstract: Imatinib mesylate (Gleevec®) is a well-established pharmacologic treatment for all phases of chronic myeloid leukemia and for advanced gastrointestinal stromal t...
Guardado en:
Autores principales: | Collin M McClelland, George J Harocopos, Philip L Custer |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b24ecbe6ffba41f2b443f72352e293e2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Periorbital muscle atrophy associated with topical bimatoprost therapy
por: Wang PX, et al.
Publicado: (2014) -
Intravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion
por: Udaondo P, et al.
Publicado: (2011) -
Nonselective ß-blocker propranolol for orbital and periorbital hemangiomas in infants: a new first-line of treatment?
por: El-Essawy R, et al.
Publicado: (2011) -
Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to retinal vein occlusion
por: Juan Carlos Mesa Gutiérrez, et al.
Publicado: (2008) -
Cystoid macular edema secondary to immune recovery uveitis in a man with cytomegalovirus retinitis and AIDS
por: Kathir Yoganathan
Publicado: (2010)